复合式小梁切除术治疗新生血管性青光眼的疗效观察

    Compound trabeculectomy for treatment of neovascular glaucoma

    • 摘要: 目的:观察复合式小梁切除术治疗新生血管性青光眼的临床疗效。方法:对13例(14眼)新生血管性青光眼患者采用复合式小梁切除术治疗,观察术后前房、眼压、视力的变化,以及并发症发生情况。结果:14眼新生血管性青光眼未发生持续性浅前房。术后并发症主要有前房炎症反应、前房出血、角膜水肿等,治疗后均吸收。术后眼压10~24 mmHg,视力提高2例,其余无变化。结论:复合式小梁切除术是治疗新生血管性青光眼安全、有效、经济的手术方法。

       

      Abstract: Objective:To investigate the efficacy of compound trabeculectomy in treatment of neovascular glaucoma. Methods:Thirteen cases(14 eyes) of neovascular glaucoma were treated by compound trabeculectomy.The anterior chamber depth,intraocular pressure,visual acuity and the complications were observed after operation.All the cases were followed up for 3 to 12 months. Results:No persistent shallow anterior chamber was observed.And postoperative complications including anterior chamber inflammation,hyphema and cornea disappeared after treatment.Postoperative intraocular pressure of the 14 cases was controlled between 10 and 24 mmHg.The visual acuity of 2 cases improved,and the others had no change. Conclusions:The compound trabeculectomy is safe,effective and economic in treatment of neovascular glaucoma.

       

    /

    返回文章
    返回